Dr. Khattak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
80 Humphreys Center Dr
Ste 330
Memphis, TN 38120Phone+1 901-752-6131Fax+1 901-752-6170
Summary
- Amna Khattak, MD is a healthcare provider who specializes in Oncology and is currently based in Memphis, TN. She completed her education with a Fellowship in Hematology and Medical Oncology, and Residency in Internal Medicine at the University of Tennessee. Dr. Khattak is now a Hematologist/Oncologist at the Baptist Cancer Center in Memphis. Her scholarly contributions include a variety of publications focused on cancer research in journals such as Federal Practitioner and J. Clin. Oncol. She has been recognized for her excellence in patient-centered care through the Patient-Centered Specialty Practice Recognition Program from the National Committee for Quality Assurance, an honor she held from 2014-2017.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of TennesseeResidency, Internal Medicine, 2006 - 2009
- OtherClass of 2004
Certifications & Licensure
- MS State Medical License 2013 - 2025
- TN State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Publications & Presentations
PubMed
- 1 citationsThe Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single Center.Jackson Reynolds, Sarah Hashimi, Ngan Nguyen, Jordan Infield, Alva Weir
Federal Practitioner. 2022-08-01 - Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.Raymond U Osarogiagbon, Jasgit C Sachdev, Amna G Khattak, Lori E Kronish
Clinical Colorectal Cancer. 2009-04-01 - Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience.Raymond U Osarogiagbon, Jasgit C Sachdev, Amna G Khattak, Lori E Kronish
Clinical Colorectal Cancer. 2009-03-01
Authored Content
- Advancing HR+ Breast Cancer Treatment: The Role of Antibody-Drug ConjugatesSeptember 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: